Professor of Pediatrics
Pediatric Hematology & Oncology
Dr. Neyssa M. Marina, MD
|
|
Give Review
Neyssa M. Marina is an expert in the field of Pediatric Hematology & Oncology. She studied medicine at University of Puerto Rico School of Medicine. She received 2 awards: "America's Top Doctors" and "America's Top Doctors for Cancer". Dr. Neyssa M. Marina is also published. She has 82 publications published. The lastest publication: "Acute hypersensitivity reactions to etoposide in a VEPA regimen for Hodgkin's disease.'
Publications
- Pilot Study of Adding Vincristine, Topotecan, and Cyclophosphamide to Interval-Compressed Chemotherapy in Newly Diagnosed Patients With Localized Ewing Sarcoma: A Repo...
- A summary of the Osteosarcoma banking efforts: a report from the Children's Oncology Group and the QuadW Foundation.
- Congenital peribronchial myofibroblastic tumor: case report of an asymptomatic infant with a rapidly enlarging pulmonary mass and review of the literature.
- Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing Sarcoma: A report from the children's oncology group.
- Comparative evaluation of local control strategies in localized Ewing Sarcoma of bone: A report from the Children's Oncology Group.
- Imputation and subset based association analysis across different Cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33.
- A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyoSarcoma, osteo...
- HER-2 expression is not prognostic in Osteosarcoma; a Children's Oncology Group prospective biology study.
- Comparison of latino and non-Latino patients with Ewing Sarcoma.
- Genome-wide association study identifies two susceptibility loci for Osteosarcoma.
- Changes in health status among aging survivors of pediatric upper and lower extremity sarcoma: a report from the childhood Cancer survivor study.
- Pediatric Acute Myeloid Leukemia as Classified Using 2008 WHO Criteria: A Single-Center Experience.
- Feasibility and dose discovery analysis of zoledronic acid with concurrent chemotherapy in the treatment of newly diagnosed metastatic Osteosarcoma: A report from the ...
- Pilot study of cisplatin, etoposide, bleomycin, and escalating dose cyclophosphamide therapy for children with high risk germ Cell tumors: A report of the children's o...
- A pilot study of low-dose anti-angiogenic chemotherapy in combination with standard multiagent chemotherapy for patients with newly diagnosed metastatic Ewing Sarcoma ...
- Outcome for adolescent and young adult patients with Osteosarcoma: A report from the Children's Oncology Group.
- Predictors of Acute chemotherapy-associated toxicity in patients with Ewing sarcoma.
- Symptom Cluster Analyses Based on Symptom Occurrence and Severity Ratings Among Pediatric Oncology Patients During Myelosuppressive Chemotherapy.
- Body mass index (BMI) at diagnosis is associated with surgical wound complications in patients with localized Osteosarcoma: A report from the Children's Oncology Group.
- High-intensity focused ultrasound (HIFU) is not indicated for treatment of primary bone Sarcomas.
- An evaluation of the factors that affect the health-related quality of life of children following myelosuppressive chemotherapy.
- Twenty years of follow-up of survivors of childhood osteosarcoma: a report from the Childhood Cancer Survivor Study.
- Changes in children's reports of symptom occurrence and severity during a course of myelosuppressive chemotherapy.
- Anti-insulin growth factor receptor therapy in Ewing Sarcoma.
- Inhaled granulocyte-macrophage colony stimulating factor for first pulmonary recurrence of osteosarcoma: effects on Disease-free survival and immunomodulation. a repor...
- Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing Sarcoma: a report from the Children's Oncology Group.
- International collaboration is feasible in trials for rare conditions: the EURAMOS experience.
- Knowledge of hepatitis C virus screening in long-term pediatric Cancer survivors: a report from the Childhood Cancer Survivor Study.
- Angiogenesis and vascular targeting in Ewing Sarcoma: a review of preclinical and clinical data.
- The role of interferons in the treatment of Osteosarcoma.
- Multiple symptoms in pediatric oncology patients: a Systematic review.
- Immune approaches to treating Osteosarcoma.
- Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of Tumors: a Children's Oncology Group Study.
- Physical performance limitations in the Childhood Cancer Survivor Study cohort.
- Phase II study of intermediate-dose cytarabine in patients with relapsed or refractory Ewing Sarcoma: a report from the Children''s Oncology Group.
- Renal function after ifosfamide, carboplatin and etoposide (ICE) chemotherapy, nephrectomy and radiotherapy in children with Wilms tumour.
- Second solid malignancies among children, adolescents, and young adults diagnosed with malignant bone Tumors after 1976: follow-up of a Children's Oncology Group cohort.
- Prognostic factors for patients with Ewing Sarcoma (EWS) at first recurrence following multi-modality therapy: A report from the Children's Oncology Group.
- Osteosarcoma: the same old drugs or more?
- Imaging guidelines for children with Ewing sarcoma and Osteosarcoma: a report from the Children's Oncology Group Bone Tumor Committee.
- Application of the adult international germ cell classification System to pediatric malignant non-seminomatous germ cell tumors: a report from the Children''s Oncology...
- Monitoring for cardiovascular disease in survivors of childhood Cancer: report from the Cardiovascular Disease Task Force of the Children's Oncology Group.
- Challenges in the recruitment of adolescents and young adults to Cancer clinical trials.
- Complementary and alternative therapy use in adult survivors of childhood Cancer: a report from the Childhood Cancer Survivor Study.
- Noninvasive evaluation of late anthracycline cardiac toxicity in childhood Cancer survivors.
- Chronic health conditions in adult survivors of childhood Cancer.
- Prognostic factors in children with extragonadal malignant germ Cell tumors: a pediatric intergroup study.
- Effect of nucleoside transport inhibitors on thymidine salvage and the toxicity of nucleoside analogs in mouse bone marrow granulocyte-macrophage progenitor Cells.
- Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-Cell tumors: a Children''s Oncology ...
- High-dose therapy and stem-Cell rescue for Ewing's family of tumors in second remission.
- Low levels of Her2/neu expressed by Ewing's family tumor Cell lines can redirect cytokine-induced killer Cells.
- Development of risk-based guidelines for pediatric Cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group La...
- Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ Cell tumors: A Pediatric Intergroup Study--Pediatric Oncology...
- Biology and therapeutic advances for pediatric Osteosarcoma.
- Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-ris...
- Biology of childhood osteogenic Sarcoma and potential targets for therapeutic development: meeting summary.
- Health status of adult long-term survivors of childhood Cancer: a report from the Childhood Cancer Survivor Study.
- Dose escalation and pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in children with solid Tumors: a pediatric oncology group study.
- Recurrent mercaptopurine-induced Acute pancreatitis: a rare complication of chemotherapy for Acute lymphoblastic leukemia in children.
- Candida tropicalis infections in children with Leukemia.
- Use of HBA 71 and anti-beta 2-microglobulin to distinguish peripheral neuroepithelioma from neuroblastoma.
- Nucleoside transport in normal and neoplastic Cells.
- Acute hypersensitivity reactions to etoposide in a VEPA regimen for Hodgkin's disease.
- A phase I study of ifosfamide with Mesna given daily for 3 consecutive days to children with malignant solid Tumors.
- Brain metastases in osteosarcoma. Report of a long-term survivor and review of the St. Jude Children's Research Hospital experience.
- Progress in the treatment of adolescents with Acute lymphoblastic leukemia.
- Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in children with relapsed solid Tumors.
- Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with Hodgkin's Disease.
- Leukemias and lymphomas in children.
- Diagnosis and treatment of the most common solid Tumors in childhood.
- Improved prognosis of children with osteosarcoma metastatic to the Lung(s) at the time of diagnosis.
- Treatment of childhood germ Cell tumors. Review of the St. Jude experience from 1979 to 1988.
- Ifosfamide plus etoposide in newly diagnosed Ewing's Sarcoma of bone.
- The role of second-look surgery in the management of advanced germ Cell malignancies.
- Candida tropicalis and Candida albicans fungemia in children with Leukemia.
- Infrared, thermistor, and glass-mercury thermometry for measurement of body temperature in children with Cancer.
- Use of MR imaging to assess results of chemotherapy for Ewing Sarcoma.
- Peripheral primitive neuroectodermal tumor (peripheral neuroepithelioma) in children. A review of the St. Jude experience and controversies in diagnosis and management.
- Age, Tumor Characteristics, and Treatment Regimen as Event Predictors in Ewing: A Children's Oncology Group Report.
- Imaging Tumor Necrosis with Ferumoxytol.
- Symptom Assessment in Pediatric Oncology: How Should Concordance Between Children's and Parents' Reports Be Evaluated?
Schools
University Of Puerto Rico School Of Medicine Medical Sciences Campus
University Ped Hospital
St Jude Hospital
Conditions Treated
- Acute Leukemia
- AdRenal Gland Cancer
- Anemia
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- View All
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
Education
-
University of Puerto Rico School of Medicine
Hospital
-
Stanford Health Care -
Lucile Packard Children's Hospital Stanford
Helpful Reviews
Similar Doctors
|
|
Dr. Jorge Dimartino, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aileen C. Cohen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alan R. Greene, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Clara Y. Lo, MD
This Doctor is OpenDoctor Recommended.
|